Rigel Pharmaceuticals financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
$4.73M $16.53M $33.47M $12.60M $0.00M $0.75M $125.00M $4.75M $2.25M $7.15M $8.25M $28.90M $20.38M $4.48M $44.51M $59.29M $108.62M $138.74M $115.74M $115.78M $0.00M
GM % Gross Margin %
0.00% -214.89% -70.19% 0.00% 0.00% 0.00% 61.53% 0.00% 0.00% 0.00% 0.00% -117.43% -211.27% 0.00% -6.02% 9.27% 43.85% 52.20% 46.41% 72.68% 0.00%
OM Operating Margin
0.00% -289.98% -128.60% 0.00% 0.00% 0.00% 28.25% 0.00% 0.00% 0.00% 0.00% -179.07% 0.00% 0.00% -163.30% -116.53% -26.67% -14.04% -50.14% -18.65% 0.00%
EPS Earnings Per Share
$-2.07 $-1.51 $-2.57 $-3.67 $-2.73 $0.72 $-1.36 $-1.32 $-1.00 $-1.04 $-0.58 $-0.67 $-0.62 $-0.44 $-0.40 $-0.18 $-0.11 $-0.34 $-0.14 $0.00
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0 0 0 0 -0.00% -0.00% 0.00% -0.00% -0.00% -0.00% -0.00% 0 0 0 -0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0
Sha. Shares
19.56m 24.16m 25.09m 31.04m 36.58m 51.82m 52.15m 71.24m 87m 87.43m 87.79m 88.53m 98.94m 146.49m 166.64m 167.61m 168.98m 170.12m 171.01m -13.62m 174.37m
OCF Operating Cash Flow
$-38.15M $-35.17M $-35.84M $-52.21M $-103.52M $-102.78M $46.74M $-69.38M $-85.21M $-86.08M $-69.75M $-23.41M $-75.89M $-77.56M $-58.83M $-41.51M $-52.19M $5.88M $-73.76M $-5.74M $0.00M
FCF Free Cash Flow
$-39.70M $-36.96M $-36.75M $-53.14M $-106.03M $-102.92M $43.18M $-71.68M $-88.57M $-87.28M $-70.17M $-23.96M $-76.69M $-77.72M $-59.93M $-42.97M $-53.45M $5.25M $-74.21M $-6.67M $0.00M
FCFS Free Cash Flow Per Share
$-2.20 $-1.69 $-1.47 $-1.84 $-2.94 $-2.52 $0.83 $-1.13 $-1.18 $-1.00 $-0.80 $-0.27 $-0.81 $-0.62 $-0.37 $-0.26 $-0.32 $0.03 $-0.43 $-0.12 $0.00